Michael Lusk

ContractMaster

My address places Council on notice that the Therapeutic Goods Act 1989 (CTH) (“TG Act”) regulates manufacturing in Australia of fluoridated drinking water. The TG Act applies because several government agencies and two industry lobby groups represent that fluoridated drinking water is for the therapeutic use of preventing dental caries. That bring...

This submission to the Legislative Council of Western Australia Environment and Public Affairs Committee (“EPA Committee”) builds on my prior submission dated 15 September 2017, in relation to which Attorney-General John Quigley made a submission in response dated 24 November 2017. The submission here presented further agitates the question as to...

The community of Bermagui (population 2000), southeastern New South Wales, Australia, supplied municipal water by BVSC, expressed concern and majority opposition to a proposal by NSW Health to impose municipal water fluoridation by 2018. BVSC water fluoridation dosage data were provided by NSW Health so that BVSC's adherence to mandatory water fluo...

On 15 August 2017 Minister Alannah MacTiernan tabled in the Legislative Council (“LC”) a petition organized by Kununurra resident Danny Carter opposing the WA Health Department’s proposal to add fluoride to Kununurra’s public water supply. The LC referred the petition to its Environment and Public Affairs Committee (“EPA Committee”). The EPA Commit...

Governments of some countries subject their populations to treatment with fluoride. These treatments may be administered on on a semi-voluntary or an involuntary basis and involve ingestion of fluoride, not topical treatment. Such treatment is purportedly a public health measure to prevent dental caries. Country-level dental health data for western...

In Germany, the Health Modernisation Act of 2004 (GMG) introduced statutory health insurance (GKV) cost savings measures intended to prevent financing problems arising from population ageing. A key measure was abolition of rebates for prescribed non-prescription medicines (OTCs). Observation of GKV pharmaceutical costs for 1999 to 2010 shows that,...